Regulus Therapeutics Inc. (RGLS)
RGLS Stock Chart More Charts
RGLS Price/Volume Stats
| Current price | $0.21 |
| Prev. close | $0.19 |
| Day low | $0.19 |
| Day high | $0.22 |
| 50-day MA | $0.25 |
| 200-day MA | $0.72 |
| 52-week high | $1.52 |
| 52-week low | $0.17 |
| Volume | 1,045,200 |
| Avg. volume | 771,750 |
| Dividend yield | N/A |
| Market Cap | 22.01M |
RGLS Returns
| 1-mo | -25.00% |
| 3-mo | -69.57% |
| 6-mo | -73.75% |
| 1-year | -83.97% |
| 3-year | -97.38% |
| 5-year | -97.78% |
| YTD | -79.81% |
| 2017 | -53.78% |
| 2016 | -74.20% |
| 2015 | -45.64% |
| 2014 | 117.05% |
| 2013 | 17.30% |
Regulus Therapeutics Inc. (RGLS) Company Bio
Regulus Therapeutics is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. The company was founded in 2007 and is based in San Diego, California.
Loading social stream, please wait...